IDNOW COVID-19
Report
- Report Number
- 1221359-2021-00699
- Event Type
- Injury
- Date Received
- March 11, 2021
- Report Date
- April 26, 2021
- Manufacturer
- ABBOTT DIAGNOSTICS SCABOROUGH
- Product Code
- QJR
- PMA / PMN Number
- EUA2000074
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- PA, US
- Reporter Occupation
- OTHER
Narratives
CUSTOMER REPORTED THE ELUTION BUFFER GOT IN HER EYE. TECHNICAL SERVICES VERIFIED THAT THE OPERATOR WAS EXAMINED AFTER THE ISSUE AND SHE WAS FINE. CUSTOMER WANTED TO CONFIRM IF THE POSITIVE PATIENT SAMPLE WAS CONTAGIOUS TO HER NOW THAT IT HAD BEEN ELUTED INTO THE SAMPLE RECEIVER AND HAD SPLASHED INTO HER EYE. TS INFORMED CUSTOMER THEY WOULD NOT CONTRACT COVID-19 FROM ELUTION BUFFER. ACCORDING TO THE PACKAGE INSERT IN190000 V6.0: PRECAUTIONS: 8. TREAT ALL SPECIMENS AS POTENTIALLY INFECTIOUS. FOLLOW UNIVERSAL PRECAUTIONS WHEN HANDLING SAMPLES, THIS KIT AND ITS CONTENTS. 14. SOLUTIONS USED TO MAKE THE POSITIVE CONTROL SWAB ARE INACTIVATED USING STANDARD METHODS. HOWEVER, PATIENT SAMPLES, CONTROLS, AND TEST PIECES SHOULD BE HANDLED AS THOUGH THEY COULD TRANSMIT DISEASE. OBSERVE ESTABLISHED PRECAUTIONS AGAINST MICROBIAL HAZARDS DURING USE AND DISPOSAL. 15. WEAR CLEAN PERSONAL PROTECTION EQUIPMENT AND GLOVES WHEN RUNNING EACH TEST. CHANGE GLOVES BETWEEN THE HANDLING OF SPECIMENS SUSPECTED OF COVID-19. 17. DO NOT OPEN THE SAMPLE RECEIVER BEFORE PLACING IN THE INSTRUMENT. IT WILL PROHIBIT THE ELUTION BUFFER FROM REACHING TEMPERATURE AND MAY IMPACT TEST PERFORMANCE. 18. IF THE SAMPLE RECEIVER IS SPILLED WHILE OPENING, CLEAN THE INSTRUMENT PER INSTRUCTIONS PROVIDED IN THE INSTRUMENT USER MANUAL AND CANCEL TEST. REPEAT TEST WITH A NEW SAMPLE RECEIVER.
THE REPORTED EVENT IS ANTICIPATED IN NATURE AND SEVERITY FOR BINAXNOW COVID-19 AG CARD AND CAPTURED WITHIN THE PRODUCT'S RISK MANAGEMENT FILE. THE CUSTOMER WAS ADVISED OF NOT CONTRACTING COVID-19 FROM ELUTION BUFFER AND WAS PROVIDED WITH DOCUMENTATION OF ID NOW BIOHAZARD SAFEGUARDS. ACCORDING TO THE INSTRUCTIONS FOR USE (IFU): PRECAUTIONS: 8. TREAT ALL SPECIMENS AS POTENTIALLY INFECTIOUS. FOLLOW UNIVERSAL PRECAUTIONS WHEN HANDLING SAMPLES, THIS KIT AND ITS CONTENTS. 14. SOLUTIONS USED TO MAKE THE POSITIVE CONTROL SWAB ARE INACTIVATED USING STANDARD METHODS. HOWEVER, PATIENT SAMPLES, CONTROLS, AND TEST PIECES SHOULD BE HANDLED AS THOUGH THEY COULD TRANSMIT DISEASE. OBSERVE ESTABLISHED PRECAUTIONS AGAINST MICROBIAL HAZARDS DURING USE AND DISPOSAL. 15. WEAR CLEAN PERSONAL PROTECTION EQUIPMENT AND GLOVES WHEN RUNNING EACH TEST. CHANGE GLOVES BETWEEN THE HANDLING OF SPECIMENS SUSPECTED OF COVID-19. 17. DO NOT OPEN THE SAMPLE RECEIVER BEFORE PLACING IN THE INSTRUMENT. IT WILL PROHIBIT THE ELUTION BUFFER FROM REACHING TEMPERATURE AND MAY IMPACT TEST PERFORMANCE. 18. IF THE SAMPLE RECEIVER IS SPILLED WHILE OPENING, CLEAN THE INSTRUMENT PER INSTRUCTIONS PROVIDED IN THE INSTRUMENT USER MANUAL AND CANCEL TEST. REPEAT TEST WITH A NEW SAMPLE RECEIVER.
THE INVESTIGATION IS STILL IN PROGRESS. A SUPPLEMENTAL REPORT WILL BE PROVIDED AFTER COMPLETION.
THE CUSTOMER REPORTED ACCIDENTALLY GETTING THE IDNOW COVID-19 ELUTION BUFFER IN THEIR EYE FROM A POSITIVE PATIENT SAMPLE ON DATE OF TEST UNKNOWN. THE CUSTOMER WAS CONCERNED ABOUT SARS-COV-2 TRANSMISSION AND INFECTION FROM THIS SAMPLE. THE CUSTOMER CONFIRMED SHE WAS EXAMINED AFTER THE EVENT AND "WAS FINE.". ATTEMPTS TO GAIN FURTHER INFORMATION WERE UNSUCCESSFUL. DUE TO CURRENT STUDIES SUGGESTING THAT THE EYE IS A POTENTIAL ROUTE FOR SARS-COV-2 TRANSMISSION AND INFECTION, ALBEIT LOW RISK COMPARED TO OTHER ROUTS OF INFECTION, MEDICAL OPINION DETERMINED THIS EVENT SHALL BE REPORTABLE. ADDITIONALLY, PER MEDICAL OPINION, REGARDLESS OF WHETHER OR NOT THE SAMPLE WAS POSITIVE FOR THE VIRUS, THIS EVENT IS CONSIDERED TO BE REPORTABLE DUE TO THE ELUTION BUFFER COMING INTO CONTACT WITH THE EYE.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 358263 | IDNOW COVID-19 | MOLECULAR IVD FOR IDNOW COVID-19 | QJR | ABBOTT DIAGNOSTICS SCABOROUGH |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | Other |